IMMULITE 2000 BR-MA L2KBR

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-10-14 for IMMULITE 2000 BR-MA L2KBR manufactured by Siemens Healthcare Diagnostics Products, Limited.

Event Text Entries

[57564353] A siemens headquarters support center (hsc) specialist reviewed the data provided by the customer. The hsc specialist informed the customer that the immulite 2000 br-ma (cancer antigen 15-3) instructions for use (ifu) states the assay is for the quantitative measurement of br-ma in human serum, as an aid in the detection of recurrence in previously treated stage ii and stage iii breast cancer patients, and in the management of metastatic breast cancer patients by monitoring disease progression or response to treatment. It is not a screening assay. The expected values section of the ifu indicates there are small percentages of samples that will recover greater than 38 u/ml (normal females 5-6%, pregnant females 10%, and females without malignant disease 26%). As noted in the ifu, ca 15-3 antigen levels in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods and reagent specificity. Results reported by the laboratory to the physician must include the identity of the assay used to measure ca 15-3 antigen levels. Values obtained with different assays cannot be used interchangeably. Before changing assays, the laboratory must confirm baseline values for patients being serially monitored. The immulite br-ma assay is a sandwich immunoassay that uses murine monoclonal antibodies to capture and detect ca 15-3 in serum. It is unknown which antibodies are used on the alternate platform. The cause of the discordant, falsely elevated br-ma results on one patient sample is unknown. The br-ma assay is performing as intended.
Patient Sequence No: 1, Text Type: N, H10


[57564354] A discordant, falsely elevated br-ma (cancer antigen 15-3) result was obtained on one patient sample on an immulite 2000 xpi instrument while using kit lot 257. It is unknown if the discordant result was reported to the physician(s). The patient underwent image testing and there was no suspicion of any type of cancer. A new sample was obtained from the customer and was tested on the same instrument using kit lot 260 and the result was still elevated. The customer sent the sample to another laboratory where the sample was tested on an alternate platform. The result on the alternate platform was lower. The result obtained on the alternate platform was reported to the physician(s). There were no reports of adverse health consequences due to the discordant, falsely elevated br-ma results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2432235-2016-00623
MDR Report Key6029671
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-10-14
Date of Report2016-10-14
Date of Event2016-02-02
Date Mfgr Received2016-09-20
Date Added to Maude2016-10-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactAARTI AZIZ
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145242683
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
Manufacturer StreetREGISTRATION #: 3002806944 GLYN RHONWY
Manufacturer CityLLANBERIS, GWYNEDD, LL554EL
Manufacturer CountryUK
Manufacturer Postal CodeLL55 4EL
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMMULITE 2000 BR-MA
Generic NameIMMULITE 2000 BR-MA
Product CodeMOI
Date Received2016-10-14
Model NumberIMMULITE 2000 BR-MA
Catalog NumberL2KBR
Lot Number237/240
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
Manufacturer AddressREGISTRATION #: 3002806944 GLYN RHONWY LLANBERIS, GWYNEDD, LL554EL UK LL55 4EL


Patients

Patient NumberTreatmentOutcomeDate
10 2016-10-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.